You are here

  • Home
  • Archive
  • Volume 9, Issue 3
  • The 2023 pipeline of disease-modifying antirheumatic drugs (DMARDs) in clinical development for spondyloarthritis (including psoriatic arthritis): a systematic review of trials

Article metrics

Article menu

Download PDFPDF

Spondyloarthritis
Original research
The 2023 pipeline of disease-modifying antirheumatic drugs (DMARDs) in clinical development for spondyloarthritis (including psoriatic arthritis): a systematic review of trials

 

Online download statistics by month:

Online download statistics by month: July 2023 to August 2024

AbstractFullPdf
Jul 2023255253213
Aug 2023820798401
Sep 2023553531148
Oct 2023476471147
Nov 2023547538131
Dec 2023496484102
Jan 202416215872
Feb 2024272266104
Mar 2024443440138
Apr 2024414409136
May 2024334325129
Jun 202423522880
Jul 202444843973
Aug 2024238227168
Total569355672042